Literature DB >> 3479682

Regulation of platelet-derived growth factor gene expression by transforming growth factor beta and phorbol ester in human leukemia cell lines.

T P Mäkelä1, R Alitalo, Y Paulsson, B Westermark, C H Heldin, K Alitalo.   

Abstract

We studied the expression of the genes encoding the A and B chains of platelet-derived growth factor (PDGF) in a number of human leukemia cell lines. Steady-state expression of the A-chain RNA was seen only in the promonocytic leukemia cell line U937 and in the T-cell leukemia cell line MOLT-4. It has previously been reported that both PDGF A and PDGF B genes are induced during megakaryoblastic differentiation of the K562 erythroleukemia cells and transiently during monocytic differentiation of the promyelocytic leukemia cell line HL-60 and U937 cells. In this study we show that PDGF A RNA expression was induced in HL-60 and Jurkat T-cell leukemia cells and increased in U937 and MOLT-4 cells after a 1- to 2-h stimulation with an 8 pM concentration of transforming growth factor beta (TGF-beta). PDGF A RNA remained at a constant, elevated level for at least 24 h in U937 cells, but returned to undetectable levels within 12 h in HL-60 cells. No PDGF A expression was induced by TGF-beta in K562 cells or in lung carcinoma cells (A549). Interestingly, essentially no PDGF B-chain (c-sis proto-oncogene) RNA was expressed simultaneously with PDGF A. In the presence of TGF-beta and protein synthesis inhibitors, PDGF A RNA was superinduced at least 20-fold in the U937 and HL-60 cells. PDGF A expression was accompanied by secretion of immunoprecipitable PDGF to the culture medium of HL-60 and U937 cells. The phorbol ester tumor promoter tetradecanoyl phorbol acetate also increased PDGF A expression with similar kinetics, but with a mechanism distinct from that of TGF-beta. These results suggest a role for TGF-beta in the differential regulation of expression of the PDGF genes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3479682      PMCID: PMC368020          DOI: 10.1128/mcb.7.10.3656-3662.1987

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  48 in total

Review 1.  Growth factors and cancer.

Authors:  A S Goustin; E B Leof; G D Shipley; H L Moses
Journal:  Cancer Res       Date:  1986-03       Impact factor: 12.701

2.  Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor beta: a proposed model for indirect mitogenesis involving autocrine activity.

Authors:  E B Leof; J A Proper; A S Goustin; G D Shipley; P E DiCorleto; H L Moses
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

3.  Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro.

Authors:  A B Roberts; M B Sporn; R K Assoian; J M Smith; N S Roche; L M Wakefield; U I Heine; L A Liotta; V Falanga; J H Kehrl
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

4.  BSC-1 growth inhibitor/type beta transforming growth factor is a strong inhibitor of thymocyte proliferation.

Authors:  H J Ristow
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

5.  Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix.

Authors:  R A Ignotz; J Massagué
Journal:  J Biol Chem       Date:  1986-03-25       Impact factor: 5.157

6.  Induction of c-sis gene expression and synthesis of platelet-derived growth factor in human myeloid leukemia cells during monocytic differentiation.

Authors:  P Pantazis; E Sariban; D Kufe; H N Antoniades
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

7.  A human osteosarcoma cell line secretes a growth factor structurally related to a homodimer of PDGF A-chains.

Authors:  C H Heldin; A Johnsson; S Wennergren; C Wernstedt; C Betsholtz; B Westermark
Journal:  Nature       Date:  1986 Feb 6-12       Impact factor: 49.962

8.  cDNA sequence and chromosomal localization of human platelet-derived growth factor A-chain and its expression in tumour cell lines.

Authors:  C Betsholtz; A Johnsson; C H Heldin; B Westermark; P Lind; M S Urdea; R Eddy; T B Shows; K Philpott; A L Mellor
Journal:  Nature       Date:  1986 Apr 24-30       Impact factor: 49.962

9.  Type beta transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells.

Authors:  T Masui; L M Wakefield; J F Lechner; M A LaVeck; M B Sporn; C C Harris
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

10.  Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth.

Authors:  J H Kehrl; L M Wakefield; A B Roberts; S Jakowlew; M Alvarez-Mon; R Derynck; M B Sporn; A S Fauci
Journal:  J Exp Med       Date:  1986-05-01       Impact factor: 14.307

View more
  15 in total

Review 1.  Kidney epithelial cells release growth factors in response to extracellular signals.

Authors:  F G Toback; M M Walsh-Reitz; S R Mendley; S Kartha
Journal:  Pediatr Nephrol       Date:  1990-07       Impact factor: 3.714

2.  Transforming growth factor beta as a potential tumor progression factor among hyperdiploid glioblastoma cultures: evidence for the role of platelet-derived growth factor.

Authors:  M T Jennings; C E Hart; P A Commers; J A Whitlock; D Martincic; R J Maciunas; P L Moots; T M Shehab
Journal:  J Neurooncol       Date:  1997-02       Impact factor: 4.130

Review 3.  Platelet-derived growth factor: mechanism of action and possible in vivo function.

Authors:  C H Heldin; B Westermark
Journal:  Cell Regul       Date:  1990-07

4.  Posttranscriptional regulation of urokinase receptor mRNA: identification of a novel urokinase receptor mRNA binding protein in human mesothelioma cells.

Authors:  S Shetty; A Kumar; S Idell
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

Review 5.  Kinase inhibitors in cancer therapy: a look ahead.

Authors:  H H Sedlacek
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

6.  Regulation of expression of the c-sis proto-oncogene.

Authors:  L Ratner
Journal:  Nucleic Acids Res       Date:  1989-06-12       Impact factor: 16.971

7.  Major structural alterations of the c-sis gene are not observed in a series of tumors of the human central nervous system.

Authors:  R D Press; A Misra; D Samols; D A Goldthwait; T B Mapstone
Journal:  J Neurooncol       Date:  1989-11       Impact factor: 4.130

8.  Cytoplasmic-nuclear shuttling of the urokinase mRNA binding protein regulates message stability.

Authors:  Sreerama Shetty
Journal:  Mol Cell Biochem       Date:  2002-08       Impact factor: 3.396

9.  Enhanced jun gene expression is an early genomic response to transforming growth factor beta stimulation.

Authors:  L Pertovaara; L Sistonen; T J Bos; P K Vogt; J Keski-Oja; K Alitalo
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

10.  Interleukin 1 regulates heparin-binding growth factor 2 gene expression in vascular smooth muscle cells.

Authors:  C G Gay; J A Winkles
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.